(Q35129551)

6 August 2017

Severe drug rashes in three siblings simultaneously (English)

1 reference

6 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

3 January 2024

author name string

L. Johnson-Reagan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752334

3 January 2024

S. L. Bahna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752334

3 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12752334

3 January 2024

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1398-9995.2003.00120.x

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1398-9995.2003.00120.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

3 January 2024

1 reference

6 August 2017

58

1 reference

6 August 2017

5

1 reference

6 August 2017

445-447

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00120.X

Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00120.X

Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00120.X

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00120.X

Clinical and Economic Impact of Adverse Drug Reactions in Hospitalized Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00120.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Drug eruptions in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00120.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Thiabendazole-induced erythema multiforme with lesions around melanocytic naevi

4

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

Thiabendazole-induced toxic epidermal necrolysis

3 January 2024

5

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

Erythema multiforme: A critical review of characteristics, diagnostic criteria, and causes

3 January 2024

6

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy

3 January 2024

7

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

Drugs as etiologic factors in the Stevens-Johnson syndrome

3 January 2024

12

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification

3 January 2024

14

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

Toxic epidermal necrolysis in children--an update

3 January 2024

15

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children

3 January 2024

16

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00120.X

3 January 2024

Identifiers

1 reference

6 August 2017

1 reference